Durvalumab 500mg/10ml Injection

Description

Introduction Of Durvalumab 500mg Injection:

Durvalumab 500mg Injection is an immune checkpoint inhibitor used mainly in the treatment of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), and is also used in certain other cancers such as biliary tract cancer and hepatocellular carcinoma.

Durvalumab 500mg Injection is administered only by a trained oncologist as an intravenous infusion, usually every 2, 3, or 4 weeks depending on the treatment plan. Your doctor will decide the dose and duration based on the type and stage of cancer, and it may be given alone or combined with chemotherapy or other cancer medicines. It should never be self-administered.

Fatigue, cough, and shortness of breath are among the most common effects of this medicine, and it can occasionally cause inflammation in the lungs or other organs due to its effect on the immune system. Inform your doctor if you notice persistent cough, difficulty breathing, severe abdominal pain, or unusual fatigue.

Uses Of Durvalumab 500mg Injection:

• Non-Small Cell Lung Cancer (NSCLC)
• Small Cell Lung Cancer (SCLC)
• Biliary Tract Cancer
• Hepatocellular Carcinoma

Benefits Of Durvalumab 500mg Injection:

1. Non-Small Cell Lung Cancer (NSCLC)

NSCLC is the most common type of lung cancer, where cancer cells can grow and spread to other tissues. Durvalumab 500mg Injection helps the immune system recognize and attack these cancer cells by blocking a protein that cancer cells use to hide from immune attack, helping slow disease progression.

2. Small Cell Lung Cancer, Biliary Tract Cancer, and Hepatocellular Carcinoma

In these cancers, Durvalumab 500mg Injection, usually combined with chemotherapy, helps activate the immune system against cancer cells, supporting better disease control as part of the overall treatment plan.

Side effects of Durvalumab 500mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Durvalumab:

• Nausea
• Vomiting
• Diarrhea
• Fatigue
• Cough
• Headache
• Fever
• Skin rash and itching
• Shortness of breath
• Loss of appetite

Machanism Of Action Of Durvalumab 500mg Injection:

Durvalumab Injection is a monoclonal antibody that works by blocking a protein called PD-L1 found on the surface of many cancer cells. PD-L1 normally helps cancer cells switch off immune cells that would otherwise attack them. By blocking PD-L1, Durvalumab restores the immune system’s ability to recognize and destroy the cancer cells, helping slow disease progression.

Contact Us